INS and obesity disorder: Furthermore, unlike β-cell failure in T2D, IR within the SM is reversible and therefore represents a clinically meaningful therapeutic target to optimise insulin sensitivity and overall metabolic efficiency and flexibility, especially in the context of obesity.